News
India's healthtech space is expected to witness disruption as weight loss drugs Ozempic and Mounjaro enter the market through ...
Inadequate supply has created opportunities for bad actors seeking to profit from shortages, high costs and demand ...
Wilde is getting more, and better, sleep now that his sleep apnea is under control, thanks to his CPAP machine and tirzepatide. Also known as Zepbound or Mounjaro, it's the same drug helping millions ...
Weight loss drugs known as GLP1s are all the rage right now. They were originally developed for diabetes and weight management, but other "off label" uses are becoming more mainstream.
Dr. Rubinstein has years of experience working with patients to help them achieve their desired goals in a realistic, ...
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...
The FDA has approved medications like Zepbound and Wegovy for weight loss, which use the same active ingredient as the ...
While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every ...
Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...
The success of Eli Lilly & Co. 's weight-loss and diabetes drugs has pushed the company's stock to new heights, helping the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results